Found: 5
Select item for more details and to access through your institution.
Impact of the kinetics of circulating anti-CD19 CAR-T cells and their populations on the outcome of DLBCL patients.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01065-z
- By:
- Publication type:
- Article
Peripheral T‐cell lymphoma with a T follicular‐helper phenotype: A different entity? Results of the Spanish Real‐T study.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 2, p. 182, doi. 10.1111/bjh.18941
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Axicabtagene Ciloleucel vs. Standard of Care in Second-Line Treatment for Relapsed/Refractory Large B-Cell Lymphoma in Spain.
- Published in:
- Cancers, 2024, v. 16, n. 13, p. 2301, doi. 10.3390/cancers16132301
- By:
- Publication type:
- Article
Lower Survival and Increased Circulating Suppressor Cells in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma with Deficit of Vitamin D Levels Using R-GDP Plus Lenalidomide (R2-GDP): Results from the R2-GDP-GOTEL Trial.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4622, doi. 10.3390/cancers13184622
- By:
- Publication type:
- Article
IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 3, p. 381, doi. 10.1007/s12185-022-03367-z
- By:
- Publication type:
- Article